Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Sohn

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
BMC Cancer|October 22, 2011
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancerMichael Eichbaum, Christine Mayer, Regina Eickhoff, et al.
Carcinogenesis|January 21, 2016
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasisDharanija Madhavan, Cike Peng, Markus Wallwiener, et al.
Breast Cancer Research and Treatment|September 27, 2018
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancerKatharina Smetanay, Philippe Junio, Manuel Feißt, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2013
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trialChristoph Domschke, Yingzi Ge, Isa Bernhardt, et al.
International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.
Radiation Oncology (London, England)|October 14, 2020
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancerDavid Krug, Christine Köder, Matthias F Häfner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2016
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implicationsStefan Stefanovic, Markus Wallwiener, Uros Karic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancerOlaf Thuerigen, Andreas Schneeweiss, Grischa Toedt, et al.
Annals of Surgical Oncology|October 16, 2015
Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate TreatmentStefan Stefanovic, Ingo Diel, Peter Sinn, et al.
Cancers|December 9, 2020
Adjuvant Radiation Therapy for Male Breast Cancer-A Rare Indication?Tobias Forster, Clara Köhler, Rami El Shafie, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
BMC Cancer|October 22, 2011
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancerMichael Eichbaum, Christine Mayer, Regina Eickhoff, et al.
Carcinogenesis|January 21, 2016
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasisDharanija Madhavan, Cike Peng, Markus Wallwiener, et al.
Breast Cancer Research and Treatment|September 27, 2018
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancerKatharina Smetanay, Philippe Junio, Manuel Feißt, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2013
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trialChristoph Domschke, Yingzi Ge, Isa Bernhardt, et al.
International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.
Radiation Oncology (London, England)|October 14, 2020
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancerDavid Krug, Christine Köder, Matthias F Häfner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2016
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implicationsStefan Stefanovic, Markus Wallwiener, Uros Karic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancerOlaf Thuerigen, Andreas Schneeweiss, Grischa Toedt, et al.
Annals of Surgical Oncology|October 16, 2015
Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate TreatmentStefan Stefanovic, Ingo Diel, Peter Sinn, et al.
Cancers|December 9, 2020
Adjuvant Radiation Therapy for Male Breast Cancer-A Rare Indication?Tobias Forster, Clara Köhler, Rami El Shafie, et al.
Pageof 26